Menu
Log in
Forgot password
Log in
Forgot password

News

  • Home
  • Resources
  • Literature Updates
  • Pathological Regression of Lymph Nodes Better Predicts Long-term Survival in Esophageal Cancer Patients Undergoing Neoadjuvant Chemotherapy Followed by Surgery

Pathological Regression of Lymph Nodes Better Predicts Long-term Survival in Esophageal Cancer Patients Undergoing Neoadjuvant Chemotherapy Followed by Surgery

01 Jun 2022 6:14 PM | Anonymous

Hagi, Takaomi MD∗; Makino, Tomoki MD, PhD, FACS∗; Yamasaki, Makoto MD, PhD∗; Yamashita, Kotaro MD, PhD∗; Tanaka, Koji MD, PhD∗; Saito, Takuro MD, PhD∗; Takahashi, Tsuyoshi MD, PhD, FACS∗; Kurokawa, Yukinori MD, PhD, FACS∗; Motoori, Masaaki MD, PhD†; Kimura, Yutaka MD, PhD‡; Nakajima, Kiyokazu MD, PhD, FACS∗; Morii, Eiichi MD, PhD§; Eguchi, Hidetoshi MD, PhD∗; Doki, Yuichiro MD, PhD∗

Read Abstract: Pathological Regression of Lymph Nodes Better Predicts Long-term Survival in Esophageal Cancer Patients Undergoing Neoadjuvant Chemotherapy Followed by Surgery

Affiliated Societies



International  Interdisciplinary  Everything Esophageal


The International Society for Diseases of the Esophagus is a 501(c)3 non-profit organization. © International Society for Disease of the Esophagus – ISDE 2024 | Any unauthorized use or reproduction of the content is prohibited without explicit permission.

General Inquiries: info@isde.net
Membership Questions: membership@isde.net

Powered by Wild Apricot Membership Software